Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02425449 · ClinicalTrials.gov registry record · Phase 4

Fade Upon TOF Stimulation Induced by Succinylcholine

A Phase 4 study, sponsored by University of Toledo Health Science Campus.

Completed
Registry status
Phase 4
Development phase
19
Enrollment target

NCT02425449: Completed Phase 4 study, sponsored by University of Toledo Health Science Campus.

NCT02425449 is a Phase 4 study that has completed, run by University of Toledo Health Science Campus. The registered enrollment target is 19 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02425449, a Phase 4 study, has completed, sponsored by University of Toledo Health Science Campus.

COMPLETED
Registry status
Phase 4
Development phase
19 participants
Enrollment target

Study Summary

Muscle relaxants are medications used during surgery to facilitate surgical access. The effect of the muscle relaxant medications is measured by stimulation a motor nerve and measuring the force of the resultant muscle contraction. Based on the mechanism of action, two kinds of muscle relaxants are described. First a nondepolarizing muscle relaxant and the second kind is the depolarizing muscle relaxant. These two kinds of muscle relaxants can be distinguished by rapidly stimulating the nerve 4 times over 2 seconds (Train of four or TOF). The nondepolarizing muscle relaxants produce fade ie successive muscle contractions are less forceful than the preceding ones. Whereas the depolarizing muscle relaxants are generally believed to produce four contractions of equal strength. However, there is some indication that this may not be entirely correct. There is evidence that depolarizing muscle relaxants also may produce fade. The investigators are conducting the following study to determine if indeed depolarizing muscle relaxants produce fade. The investigators would also like to characterize the fade ie differences during onset and offset of the block and the effect of the dose on the degree on the fade.

Primary Outcome

We stimulated the ulnar nerve at the wrist four times (over 1.5 seconds) every 20 seconds. We measured the ratio of the fourth contraction to the first contraction before and after the administration of succinylcholine. Before administering succinylcholine the ratio is normally one. After the administration of succinylcholine the first contraction diminishes, but the fourth contraction diminishes even more. This results in a ratio of T4 to T1 being less than one. The lowest ratio recorded after

Interventions

  • DRUG Succinylcholine

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2015-04
Est. Completion 2017-01-04
Phase Phase 4

What the finished NCT02425449 record still lists

NCT02425449 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Succinylcholine is the first listed.

NCT02425449 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02425449 about?

NCT02425449 is a clinical study titled "Fade Upon TOF Stimulation Induced by Succinylcholine". Muscle relaxants are medications used during surgery to facilitate surgical access. The effect of the muscle relaxant medications is measured by stimulation a motor nerve and measuring the force of the resultant muscle contraction. Based on the mechanism of action, two kinds of muscle relaxants are ...

What is the current status of trial NCT02425449?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2015-04. Estimated completion is 2017-01-04.

What interventions are being tested in trial NCT02425449?

The interventions under investigation include: Succinylcholine (DRUG).

Who is sponsoring clinical trial NCT02425449?

This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02425449's enrollment target sits among peer trials

19 1834th of 2000 higher than 159 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02425449, the US trial registry maintained by the National Library of Medicine. NCT02425449 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.